Comment from EMD Serono

Summary: EMD Serono, the healthcare business of Merck KGaA, supports the Commissioner’s National Priority Voucher (CNPV) Pilot Program as an innovative way to accelerate the development of products addressing national priorities. While expressing support, the company requests more clarity and consistent guidance regarding pre-eligibility feedback, readiness expectations at voucher redemption, and interactions with existing expedited programs.